Therapeutic Solutions International Files Patent o
Post# of 208
(Total Views: 418)
Posted On: 07/28/2020 10:11:23 AM
Therapeutic Solutions International Files Patent on Ability of QuadraMune Ingredient Pterostilbene to Reduce Inflammation while Stimulating Brain Protective Biological Pathways
Mechanistic Studies Continuing on QuadraMune™ a COVID19 Candidate in Clinical Trial
Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies
https://www.prnewswire.com/news-releases/ther...01258.html
Mechanistic Studies Continuing on QuadraMune™ a COVID19 Candidate in Clinical Trial
Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies
https://www.prnewswire.com/news-releases/ther...01258.html
(0)
(0)Therapeutic Solutions International Inc (TSOI) Stock Research Links
Scroll down for more posts ▼